S1 guideline diagnosis and therapy of cutaneous larva migrans (creeping disease)

These guidelines aim to enhance patient care by optimizing the diagnosis and treatment of infections due to creeping disease (cutaneous larva migrans) and to raise awareness among doctors of current treatment options.

[1]  S. Regnier,et al.  The efficacy of single dose ivermectin in the treatment of hookworm related cutaneous larva migrans varies depending on the clinical presentation , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[2]  F. Reichert,et al.  Hookworm-related cutaneous larva migrans in northern Brazil: resolution of clinical pathology after a single dose of ivermectin. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  S. Veraldi,et al.  Chronic hookworm-related cutaneous larva migrans. , 2013, International Journal of Infectious Diseases.

[4]  S. Bottini,et al.  One-week therapy with oral albendazole in hookworm-related cutaneous larva migrans: A retrospective study on 78 patients , 2012, The Journal of dermatological treatment.

[5]  H. Feldmeier,et al.  Mini review: hookworm-related cutaneous larva migrans , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[6]  J. Utzinger,et al.  Efficacy of Single-Dose and Triple-Dose Albendazole and Mebendazole against Soil-Transmitted Helminths and Taenia spp.: A Randomized Controlled Trial , 2011, PloS one.

[7]  P. Buffet,et al.  Individual Variability of the Cutaneous Larva Migrans (CLM) Incubation Period , 2010, Pediatric dermatology.

[8]  S. Puente,et al.  Patología dermatológica y medicina tropical. Resultados de un estudio prospectivo (2004-2007) , 2009 .

[9]  P. Rivas González,et al.  [Skin diseases and tropical medicine. Results from a prospective study (2004-2007)]. , 2009, Revista clínica española (Ed. impresa).

[10]  J. Keystone,et al.  Dermatologic conditions of the ill returned traveler: an analysis from the GeoSentinel Surveillance Network. , 2008, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[11]  N. Beeching,et al.  Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis. , 2008, International journal of antimicrobial agents.

[12]  E. Caumes,et al.  Hookworm-related cutaneous larva migrans. , 2007, Journal of travel medicine.

[13]  E. Caumes.  Efficacy of albendazole ointment on cutaneous larva migrans in 2 young children. , 2004, Clinical Infectious Diseases.

[14]  F. Fusco,et al.  Outbreak of cutaneous larva migrans in Naples, southern Italy. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[15]  F. Vega‐López,et al.  Cutaneous larva migrans: clinical features and management of 44 cases presenting in the returning traveller , 2001, The British journal of dermatology.

[16]  G. Galbiati,et al.  Treatment of larva migrans cutanea (creeping eruption): a comparison between albendazole and traditional therapy , 2001, International journal of dermatology.

[17]  R. Durand,et al.  Cutaneous larva migrans in travelers: a prospective study, with assessment of therapy with ivermectin. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  E. Caumes.  Treatment of cutaneous larva migrans. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  C. Fumelli,et al.  Treatment of scabies with ivermectin. , 1999, European journal of dermatology : EJD.

[20]  E. van den Enden,et al.  Treatment of cutaneous larva migrans. , 1998, The New England journal of medicine.

[21]  E. Caumes,et al.  Dermatoses associated with travel to tropical countries: a prospective study of the diagnosis and management of 269 patients presenting to a tropical disease unit. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  E. Caumes,et al.  A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans. , 1993, The American journal of tropical medicine and hygiene.

[23]  F. Ochsendorf,et al.  [Current therapeutic possibilities in cutaneous larva migrans]. , 1993, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[24]  Louis Fj,et al.  [Value of single-dose ivermectin in the treatment of cutaneous larva migrans syndrome]. , 1992 .

[25]  E. Caumes,et al.  Efficacy of ivermectin in the therapy of cutaneous larva migrans. , 1992, Archives of dermatology.

[26]  F. Louis,et al.  [Value of single-dose ivermectin in the treatment of cutaneous larva migrans syndrome]. , 1992, Presse medicale.

[27]  S. Sanguigni,et al.  Albendazole in the therapy of cutaneous larva migrans. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.